Home › Funds › Ikarian Capital, LLC › PRQR

Ikarian Capital, LLC position in PRQR

PROQR THRAPEUTICS N V · Health Care

Ikarian Capital, LLC reported holding 3,425,930 shares of PRQR (PROQR THRAPEUTICS N V) in its Q2 2026 13F filing — a position valued at US$6.4M, representing 1.02% of its reported portfolio and ranking #30 among its reported holdings. Ikarian Capital, LLC has disclosed PRQR holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.43M sh
Reported value held$6.37M
Portfolio Weight1.02%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's PRQR position evolved

Ikarian Capital, LLC first disclosed a stake in PRQR in Q3 2023 at 472,625 shares (US$614K). The position peaked in Q2 2026 at 3,425,930 shares, worth US$6.4M. Across 10 filings, Ikarian Capital, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 3,425,930 shares valued at US$6.4M — an increase of 1,933,701 shares quarter over quarter.. Notable position changes include a 67% increase in Q4 2025 (shares fell 20% over the following quarter), a 130% increase in Q2 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 472.62K $614.41K New
Q4 2023 472.62K $935.80K Hold
Q1 2024 483.58K $1.10M Add
Q2 2024 483.58K $802.75K Hold
Q3 2024 483.58K $880.12K Hold
Q2 2025 868.07K $1.77M New
Q3 2025 892.23K $1.90M Add
Q4 2025 1.49M $3.01M Add
Q1 2026 1.49M $2.42M Hold
Q2 2026 3.43M $6.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRQR and 13F data

PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 35 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$10.3M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M), Kynam Capital Management, LP (US$2.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRQR

All PRQR fund holders →

FAQ

How long has Ikarian Capital, LLC held PRQR?

Ikarian Capital, LLC has disclosed PRQR holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Ikarian Capital, LLC's current position in PRQR?

As of Q2 2026, Ikarian Capital, LLC holds 3.43M shares of PRQR (PROQR THRAPEUTICS N V), valued at $6.37M, representing 1.02% of its reported portfolio and ranking #30.

Has Ikarian Capital, LLC been buying or selling PRQR?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC increased its position in PRQR. The position peaked in Q2 2026 at 3.43M shares.

Which other funds hold PRQR?

Other major institutional holders of PRQR include Privium Fund Management B.V., HEIGHTS CAPITAL MANAGEMENT, INC, Kynam Capital Management, LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.